col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


130 Results       Page 1

 [1] 
Springer-Verlag: Inflammopharmacology
  original article Date Title Authors   All Authors
1 [GO] 2026―Apr―20 Safety and efficacy of COVID-19 vaccines in pregnant and lactating women: a comprehensive review Sumel Ashique, Mohini Mondal, Md Sadique Hussain, Anas Islam, Mohd Tariq, Dinesh Kumar Chellappan, et al. (+4)
2 [GO] 2025―Dec―22 Long COVID: a review of mechanisms and treatment modalities Mabel Yet, Hui Sheung Teo, Hannah Kwa, Joseph Yeo, Samuel S. Y. Wang
3 [GO] 2025―Dec―18 SARS-CoV-2 infection and gut-lung axis: the potential role of rifaximin Taghreed N. Almanaa, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Maii A. Abdelnaby, Athanasios Alexiou, Marios Papadakis, et al. (+2)
4 [GO] 2025―Nov―30 Lingering echoes of SARS-CoV-2: mechanistic insights and management of long COVID syndrome Jagat Pal Yadav, Seema Yadav, Nimesh Kumar Dubey, Indra Pal Yadav, Prateek Pathak, Amita Verma
5 [GO] 2025―Nov―22 Persistent inflammatory cytokine signature in long Covid-19 patients: a meta-analysis Waleska Dornas, João Pedro Reis, Tales Eduardo Belilo, Leonardo Gomes Vaz, Helena Horta Nasser, Maria de Lourdes de Souza Maia, et al. (+5)
6 [GO] 2025―Oct―13 From infection to intervention: post-acute sequelae of SARS-CoV-2 infection and cardiovascular risk Rufaida Wasim
7 [GO] 2025―Sep―24 Unveiling the secret of cellular metamorphosis: the crucial role of EndMT mechanisms in COVID-19-induced pulmonary fibrosis Xin Zhang, Xia Tong, Ruijie Hou, Pengbo Wang, Yan Mo, Lanlan Zhang
8 [GO] 2025―Aug―29 MicroRNAs in SARS-CoV-2 infection: emerging modulators of inflammation, pathogenesis, and therapeutic potential Mohammad Fayyad-Kazan
9 [GO] 2025―Aug―27 The potential role of carvedilol in COVID-19 management: perspective and take-away Hayder M. Al-Kuraishy, Maii A. Abdelnaby, Marios Papadakis, Athanasios Alexiou, Gaber El-Saber Batiha
10 [GO] 2025―Aug―12 COVID-19 in comorbid chronic diseased patients, pregnant and lactating women: pathophysiology, available drug treatment, and the most suitable protocol regimen in each group Hend M. Mohamed, Yara Y. Elkholy, Yara M. Mokhtar, Mirna A. Orady, Heba Sh. Elmetwaly, Hend Mo. Abdelwahab, et al. (+3)
11 [GO] 2025―Jul―29 Effect of N-Acetylcysteine on mortality in COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam
12 [GO] 2025―Jul―07 Long COVID syndrome: exploring therapies for managing and overcoming persistent symptoms Dhrita Chatterjee, Kousik Maparu
13 [GO] 2025―Jul―01 Aryl-hydrocarbon receptor dysregulation and its correlation with immunomodulatory markers in COVID-19 patients Abeda Mazari, Mohammad Hossein Nicknam, Sara Assadiasl, Maryam Sadr, Hanieh Mojtahedi, Maryam Ahmadi, et al. (+3)
14 [GO] 2025―Apr―12 Correction: Vitamin D: a key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants Hussein Sabit, Shaimaa Abdel-Ghany, Mahmoud S. Abdallah, Osama Abul-Maaty, Ahmed I. Khoder, Nabil A. Shoman, et al. (+4)
15 [GO] 2025―Mar―08 The association between glucocorticoids and long COVID Yan Zhao, Guangting Zeng
16 [GO] 2025―Feb―21 Long COVID has variable incidence and clinical presentations: our 6-country collaborative study Sandor Szabo, Iryna Muzyka, Veronika Muller, Attila J. Szabo, Attila Szijártó, Klara Gyires, et al. (+10)
17 [GO] 2024―Dec―23 Across-the-board review on Omicron SARS-CoV-2 variant Rufaida Wasim, Asad Ahmad
18 [GO] 2024―Nov―27 Evaluating diclofenac’s risks in COVID-19: strategies for mitigating adverse outcomes Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam
19 [GO] 2024―Nov―13 Role of intravenous vitamin C on outcomes in hospitalized patients with moderate or severe COVID-19: a real life data of Turkish patients Burak Uz, Özgür İnce, Can Gümüş, Feyzi Gökosmanoğlu, Emrah Gökay Özgür, Gülnaz Nural Bekiroğlu
20 [GO] 2024―Oct―16 Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants Hussein Sabit, Shaimaa Abdel-Ghany, Mahmoud S. Abdallah, Osama Abul-Maaty, Ahmed I. Khoder, Nabil A. Shoman, et al. (+4)
21 [GO] 2024―Oct―03 Glucocorticoid treatment during COVID-19 infection: does it affect the incidence of long COVID? Polina Specktor, Dana Hadar, Hilla Cohen
22 [GO] 2024―Sep―23 The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study Narmeen Mallah, Irene Visos-Varela, Bahi Takkouche, Rosendo Bugarín-González, María Piñeiro-Lamas, Teresa Herdeiro, et al. (+16)
23 [GO] 2024―Sep―03 The impact of vitamin D administration on mortality in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Zhiyun Wong, Kaeshaelya Thiruchelvam
24 [GO] 2024―Aug―10 Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management Samar A. Antar, Nada A. Ashour, Amir O. Hamouda, Ayman M. Noreddin, Ahmed A. Al-Karmalawy
25 [GO] 2024―Aug―09 Impact of corticosteroid doses on prognosis of severe and critical COVID-19 patients with Omicron variant infection: a propensity score matching study Shiyao Wang, Ziying Chen, Xinran Zhang, Xiaojing Wu, Yuqiong Wang, Qi Zhang, et al. (+8)
26 [GO] 2024―Jul―24 Taming the storm: potential anti-inflammatory compounds targeting SARS-CoV-2 MPro Débora Bublitz Anton, Jeferson Camargo de Lima, Bruno Rampanelli Dahmer, Ana Micaela Camini, Marcia Inês Goettert, Luis Fernando Saraiva Macedo Timmers
27 [GO] 2024―May―21 Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols Abdul Mannan Baig, Sandy Rosko, Beate Jaeger, Joachim Gerlach, Hans Rausch
28 [GO] 2024―May―19 Surveying haemoperfusion impact on COVID-19 from machine learning using Shapley values Behzad Einollahi, Mohammad Javanbakht, Mehrdad Ebrahimi, Mohammad Ahmadi, Morteza Izadi, Sholeh Ghasemi, et al. (+4)
29 [GO] 2024―May―02 Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study Almudena Rodríguez-Fernández, Irene Visos-Varela, Maruxa Zapata-Cachafeiro, Samuel Pintos-Rodríguez, Rosa M. García-Álvarez, Teresa M. Herdeiro, et al. (+17)
30 [GO] 2024―Apr―15 Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient Rosa María García-Álvarez, Maruxa Zapata-Cachafeiro, Irene Visos-Varela, Almudena Rodríguez-Fernández, Samuel Pintos-Rodríguez, Maria Piñeiro-Lamas, et al. (+12)
31 [GO] 2024―Mar―16 Evaluation of the relationship of treatment and vaccination with prognosis in patients with a diagnosis of COVID-19 Seyma Oncu, Derya Korkmaz
32 [GO] 2024―Jan―31 Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach Mina T. Kelleni
33 [GO] 2023―Dec―20 Mesenchymal stem cell therapy for COVID-19 infection Seyyed Mohammad Matin Alavi-Dana, Yazdan Gholami, Mohammadreza Meghdadi, Mohammad Saleh Fadaei, Vahid Reza Askari
34 [GO] 2023―Dec―14 Intravenous immunoglobulin for treatment of hospitalized COVID-19 patients: an evidence mapping and meta-analysis Mei-xuan Li, Yan-fei Li, Xin Xing, Jun-qiang Niu, Liang Yao, Meng-ying Lu, et al. (+15)
35 [GO] 2023―Nov―27 Therapeutic potential and possible mechanisms of ginseng for depression associated with COVID-19 Fangyi Zhao, Kai Zhang, Hongyu Chen, Tianqi Zhang, Jiayu Zhao, Qianyu Lv, et al. (+4)
36 [GO] 2023―Nov―13 Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19: recent studies confirm clinical validation and highlight metformin to improve VDR sensitivity and efficacy Adel A. Gomaa, Yasmin A. Abdel-Wadood, Romany H. Thabet, Ghada A. Gomaa
37 [GO] 2023―Oct―17 Efficacy and safety of licorice (Glycyrrhiza glabra) in moderately ill patients with COVID-19: a randomized controlled trial Ali Ameri, Mehdi Farashahinejad, Parivash Davoodian, Omid Safa, Amin Kusha, Habib Dadvand, et al. (+2)
38 [GO] 2023―Oct―17 The effect of probiotics on the risk of mortality in patients with COVID-19: systematic review and meta-analysis of randomized trials Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
39 [GO] 2023―Oct―16 The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression Arto Yuwono Soeroto, Hendarsyah Suryadinata, Theo Audi Yanto, Timotius Ivan Hariyanto
40 [GO] 2023―Oct―13 Cytokine profiles in COVID-19 patients undergoing adjunct ozone therapy: some comments Salvatore Chirumbolo, Sergio Pandolfi, Marianno Franzini, Luigi Valdenassi
41 [GO] 2023―Oct―09 Purinergic signaling: decoding its role in COVID-19 pathogenesis and promising treatment strategies Zahra Shafaghat, Amir-Hossein Khosrozadeh Ghomi, Hossein Khorramdelazad, Elaheh Safari
42 [GO] 2023―Oct―07 Systematic review and meta-analysis of anti-CD20 treatments in patients with COVID-19: an assessment of severe illness and mortality outcomes Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam
43 [GO] 2023―Sep―29 Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers Pavlo Petakh, Iryna Kamyshna, Aleksandr Kamyshnyi
44 [GO] 2023―Aug―21 Ibuprofen, other NSAIDs and COVID-19: a narrative review William Laughey, Imran Lodhi, Graham Pennick, Lucinda Smart, Olutoba Sanni, Suneet Sandhu, Bruce Charlesworth
45 [GO] 2023―Aug―07 Combined systemic inflammatory indexes as reflectors of outcome in patients with COVID-19 infection admitted to ICU Amir Tahavvori, Reza Mosaddeghi-Heris, Faezeh Ghanbari Sevari, Seyed Mohammad Amin Alavi, Peghah Panahi, Niloufar Abbasi, et al. (+2)
46 [GO] 2023―Jul―17 Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID Tamás Constantin, Tamás Pék, Zsuzsanna Horváth, Diána Garan, Attila J. Szabó
47 [GO] 2023―Jul―15 Effect of treatment regimen of the rheumatoid arthritis patients on the risk of coronavirus disease 2019 by modulating the inflammatory mediators Zahra Bagheri-Hosseinabadi, Alireza Dehghani, Mohammad Amin Lotfi, Mitra Abbasifard
48 [GO] 2023―Jul―12 Cytokine profile and antioxidants status in the moderate and severe COVID-19 patients: a trial of ozone therapy impact as a medicinal supplement Hadi Esmaeili Gouvarchin Ghaleh, Morteza Izadi, Mohammad Javanbakht, Mostafa Ghanei, Behzad Einollahi, Nematollah Jonaidi Jafari, et al. (+11)
49 [GO] 2023―Jun―21 Long COVID and possible preventive options Szilvia Sebők, Klara Gyires
50 [GO] 2023―Jun―16 The African Kelleni’s roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one Mina T. Kelleni
51 [GO] 2023―Jun―02 Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support: a systematic review and meta-analysis of randomized trials Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
52 [GO] 2023―Jun―01 Nutritional deficiencies and long COVID: correspondence Amnuay Kleebayoon, Viroj Wiwanitkit
53 [GO] 2023―May―19 Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Nada A. Ashour, Walaa A. Negm
54 [GO] 2023―May―15 The post-COVID stress syndrome: from the three-stage stress response of Hans Selye to COVID-19 Sandor Szabo
55 [GO] 2023―Apr―20 Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami Yasamin Sharbatdar, Ronak Mousavian, Seyed Mostafa Noorbakhsh Varnosfaderani, Fatemeh Aziziyan, Mahsa Liaghat, Payam Baziyar, et al. (+6)
56 [GO] 2023―Apr―18 The effect of vitamin C on the risk of mortality in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials Chia Siang Kow, Syed Shahzad Hasan, Dinesh Sangarran Ramachandram
57 [GO] 2023―Apr―10 Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19 Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
58 [GO] 2023―Apr―05 Fatigue, sleepiness and sleep quality are SARS-CoV-2 variant independent in patients with long COVID symptoms Anna Reka Percze, Alexandra Nagy, Lorinc Polivka, Eniko Barczi, Ibolya Czaller, Zsuzsanna Kovats, et al. (+4)
59 [GO] 2023―Mar―26 Real-world practice of the Egyptian Kelleni’s protocol amid changing tropism of SARS-CoV-2 omicron BA.5.2.1.7, XBB 1.5 and CH.1.1 subvariants: a multi-purpose protocol Mina T. Kelleni
60 [GO] 2023―Mar―25 What is the role of brown adipose tissue in metabolic health: lessons learned and future perspectives in the long COVID? Iryna Muzyka, Oleh Revenko, Iryna Kovalchuk, Maryanna Savytska, Anna Bekesevych, Roksolana Kasko, Oksana Zayachkivska
61 [GO] 2023―Mar―24 Post-COVID interstitial lung disease in symptomatic patients after COVID-19 disease Dorottya Fesu, Lorinc Polivka, Eniko Barczi, Marcell Foldesi, Gabor Horvath, Edit Hidvegi, et al. (+2)
62 [GO] 2023―Mar―22 Long COVID prevalence and physiology-centered risks: population-based study in Ukraine Iryna Muzyka, Mariana Yakhnytska, Maryana Savytska, Oksana Zayachkivska
63 [GO] 2023―Mar―21 What is the role of brown adipose tissue in metabolic health: lessons learned and future perspectives in the long COVID? Iryna Muzyka, Oleh Revenko, Iryna Kovalchuk, Maryanna Savytska, Anna Bekesevych, Oksana Zayachkivska
64 [GO] 2023―Mar―15 Nutritional deficiencies that may predispose to long COVID John V. Schloss
65 [GO] 2023―Mar―09 COVID-19-induced neurological symptoms: focus on the role of metal ions Yi-Yue Zhang, Kai-Di Ren, Xiu-Ju Luo, Jun Peng
66 [GO] 2023―Feb―27 Could the fibromyalgia syndrome be triggered or enhanced by COVID-19? Maria Fernanda Pessano Fialho, Evelyne Silva Brum, Sara Marchesan Oliveira
67 [GO] 2023―Feb―01 The direct correlation between microbiota and SARS-CoV-2 infectious disease Antonio Vitiello, Francesco Ferrara, Andrea Zovi
68 [GO] 2023―Jan―27 High-dose intravenous anakinra treatment is safe and effective in severe and critical COVID-19 patients: a propensity score-matched study in a single center Murat Bektaş, Servet Yüce, Mustafa Ay, Muhammed Hamdi Uyar, Mustafa Erkut Önder, Muhammed İkbal Kılıç
69 [GO] 2023―Jan―07 A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective? Mohsen Nabi-Afjadi, Fatemeh Mohebi, Hamidreza Zalpoor, Fatemeh Aziziyan, Abdullatif Akbari, Hemen Moradi-Sardareh, et al. (+3)
70 [GO] 2023―Jan―04 Critical roles of cytokine storm and bacterial infection in patients with COVID-19: therapeutic potential of mesenchymal stem cells Babak Arjmand, Sepideh Alavi-Moghadam, Masoumeh Sarvari, Mostafa Rezaei-Tavirani, Ahmad Rezazadeh- Mafi, Rasta Arjmand, et al. (+3)
71 [GO] 2022―Dec―20 The effect of ramatroban on cytokine and thrombotic storms in Covid-19 Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Hebatallah M. Saad, Gaber El-Saber Batiha
72 [GO] 2022―Dec―09 A perspective study of the possible impact of obeticholic acid against SARS-CoV-2 infection Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Fadia S. Youssef, Suzy A. El-Sherbeni, Walaa A. Negm
73 [GO] 2022―Nov―29 Efficacy and safety of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in COVID-19 patients: a meta-analysis An-ran Xi, Yi-jun Luo, Jin-Tao Guan, Wei-Jie Wang, Zheng-Hao Xu
74 [GO] 2022―Nov―24 Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Mubarak Alruwaili, Raed AlRuwaili, Sarah M. Albogami, et al. (+3)
75 [GO] 2022―Nov―19 Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial Ali Ameri, Masoomeh Frouz Asadi, Ava Ziaei, Majid Vatankhah, Omid Safa, Manoochehr Kamali, et al. (+3)
76 [GO] 2022―Oct―25 Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines Sevilay Batıbay, Rezan Koçak Ulucaköy, Zafer Günendi, Işıl Fidan, Gülendam Bozdayı, Feride Nur Göğüş
77 [GO] 2022―Oct―02 The role of berberine in Covid-19: potential adjunct therapy Ahmad O. Babalghith, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Michel De Waard, Sadiq Mohammed Al-Hamash, Sabatier Jean-Marc, et al. (+2)
78 [GO] 2022―Sep―30 Is sitagliptin effective for SARS-CoV-2 infection: false or true prophecy? Basil Mohammed Alomair, Hayder M. Al-kuraishy, Ali K. Al-Buhadily, Ali I. Al-Gareeb, Michel De Waard, Engy Elekhnawy, Gaber El-Saber Batiha
79 [GO] 2022―Sep―22 Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild-moderate COVID-19 and prevention of post-COVID cognitive impairment Adel A. Gomaa, Yasmin A. Abdel-Wadood, Mohamed A. Gomaa
80 [GO] 2022―Sep―16 Potential role of lipoxin in the management of COVID-19: a narrative review Gaber El-Saber Batiha, Ali I. Al-Gareeb, Engy Elekhnawy, Hayder M. Al-kuraishy
81 [GO] 2022―Sep―12 Association between chemosensory dysfunctions and inflammatory biomarkers in patients with SARS-CoV-2 infection: a systematic review and meta-analysis Elisama Gomes Magalhães de Melo, Rayle Monteiro Andrade, Sara Juliana de Abreu de Vasconcellos, Priscila Lima dos Santos, Diego Moura Tanajura, Lucindo José Quintans-Júnior, et al. (+2)
82 [GO] 2022―Sep―01 Lycopene: a therapeutic strategy against coronavirus disease 19 (COVID- 19) Banlambhabok Khongthaw, Kanika Dulta, Pankaj Kumar Chauhan, Vinod Kumar, Joshua O. Ighalo
83 [GO] 2022―Aug―26 Dysregulation of immunity in COVID-19 and SLE Seyyed Sina Hejazian, Seyyedeh Mina Hejazian, Farahnoosh Farnood, Sima Abedi Azar
84 [GO] 2022―Aug―26 Assessment of drugs administered in the Middle East as part of the COVID-19 management protocols Engy Elekhnawy, Walaa A. Negm, Suzy A. El-Sherbeni, Ahmed Zayed
85 [GO] 2022―Aug―22 Hesperetin as an anti-SARS-CoV-2 agent can inhibit COVID-19-associated cancer progression by suppressing intracellular signaling pathways Hamidreza Zalpoor, Maryam Bakhtiyari, Hooriyeh Shapourian, Puria Rostampour, Chanour Tavakol, Mohsen Nabi-Afjadi
86 [GO] 2022―Aug―18 Nirmatrelvir-remdesivir association for non-hospitalized adults with COVID-19, point of view Francesco Ferrara, Andrea Zovi, Ugo Trama, Antonio Vitiello
87 [GO] 2022―Aug―10 Pathogenic role of cytokines in COVID-19, its association with contributing co-morbidities and possible therapeutic regimens Ayesha Tanveer, Bushra Akhtar, Ali Sharif, Uzma Saleem, Azhar Rasul, Aftab Ahmad, Kashif Jilani
88 [GO] 2022―Aug―03 Ursolic acid and SARS-CoV-2 infection: a new horizon and perspective Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Walaa A. Negm, Athanasios Alexiou, Gaber El-Saber Batiha
89 [GO] 2022―Jul―27 Effects of Boswellia species on viral infections with particular attention to SARS-CoV-2 Zahra Jamshidi, Maryam Hashemi, Rezvan Yazdian-Robati, Leila Etemad, Zahra Salmasi, Prashant Kesharwani
90 [GO] 2022―Jul―14 Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients Habib Ghaznavi, Zahra Mohammadghasemipour, Milad Shirvaliloo, Mohammad Kazem Momeni, Malihe Metanat, Farzaneh Gorgani, et al. (+8)
91 [GO] 2022―Jun―20 Evaluating the effect of Edaravone on clinical outcome of patients with severe COVID-19 admitted to ICU: a randomized clinical trial Mohammadreza Moslemi, Seyyedeh Mina Hejazian, Molod Shaddelan, Fatemeh Javanali, Alireza Mirghaffari, Armin Sadeghi, et al. (+5)
92 [GO] 2022―Jun―14 The impact of SARS-CoV-2 treatment on the cardiovascular system: an updated review Mohammed Ahmed Akkaif, Abubakar Sha’aban, Arturo Cesaro, Ammar Ali Saleh Jaber, Andrea Vergara, Ismaeel Yunusa, et al. (+6)
93 [GO] 2022―May―30 The key role of Calpain in COVID-19 as a therapeutic strategy Aref Doozandeh Juibari, Mohammad Hossein Rezadoost, Masoud Soleimani
94 [GO] 2022―May―30 Histopathological and molecular links of COVID-19 with novel clinical manifestations for the management of coronavirus-like complications Ankita Sood, Onkar Bedi
95 [GO] 2022―May―13 COVID-19 and corticosteroids: a narrative review Gaber El-Saber Batiha, Ali I. Al-Gareeb, Hebatallah M. Saad, Hayder M. Al-kuraishy
96 [GO] 2022―May―04 COVID-19 and the role of cytokines in this disease Amin Hasanvand
97 [GO] 2022―Apr―29 A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19 Gomaa Mostafa-Hedeab, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Philippe Jeandet, Hebatallah M. Saad, Gaber El-Saber Batiha
98 [GO] 2022―Apr―26 High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Luay Alkazmi, Ola A. Habotta, Gaber El-Saber Batiha
99 [GO] 2022―Apr―07 Potential plants for inflammatory dysfunction in the SARS-CoV-2 infection Diorge Jônatas Marmitt
100 [GO] 2022―Mar―28 Role of triggering receptor expressed on myeloid cells-1 (TREM-1) in COVID-19 and other viral pneumonias: a systematic review and meta-analysis of clinical studies Yrna Lorena Matos de Oliveira, Ayane de Sá Resende, Paulo Ricardo Martins-Filho, Tatiana Rodrigues de Moura
101 [GO] 2022―Mar―23 Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR Nourin Shakeeb, Prashanth Varkey, Aimy Hynse, Ajit Mandlecha
102 [GO] 2022―Mar―22 Comment on “Inflawell, neutrophil-to-lymphocyte ratio and COVID-19” Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
103 [GO] 2022―Mar―01 Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial Adel A. Gomaa, Hamdy S. Mohamed, Rasha B. Abd-ellatief, Mohamed A. Gomaa, Doaa S. Hammam
104 [GO] 2022―Feb―24 Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial Sepideh Barzin Tond, Laurent Balenci, Nasim Khajavirad, Mohammadreza Salehi, Abbas Tafakhori, Mohammad Reza Shahmohammadi, et al. (+13)
105 [GO] 2022―Feb―14 Selenium, selenoprotein P, and oxidative stress levels in SARS-CoV-2 patients during illness and recovery A. Skesters, D. Kustovs, A. Lece, E. Moreino, E. Petrosina, K. D. Rainsford
106 [GO] 2022―Jan―31 Evaluation serum levels of Insulin Growth Factor-1 (IGF-1) and its association with clinical parameters in severe COVID-19 Parisa Feizollahi, Somaieh matin, Seyed Askar Roghani, Shayan Mostafaei, Elham Safarzadeh, Mahdi Taghadosi
107 [GO] 2022―Jan―31 The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis Chia Siang Chia Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
108 [GO] 2022―Jan―20 Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, Suresh Sharma, Yogendra S. Padwad, Sanjay Kumar
109 [GO] 2022―Jan―03 Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination Rupinder Kaur, Shareen Singh, Thakur Gurjeet Singh, Pragati Sood, Jiki Robert
110 [GO] 2021―Dec―20 Correction to: The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case-control study Mahsa Mohajeri, Ehsan Horriatkhah, Reza Mohajery
111 [GO] 2021―Nov―25 NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown? Mina T. Kelleni
112 [GO] 2021―Oct―28 The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case-control study Mahsa Mohajeri, Ehsan Horriatkhah, Reza Mohajery
113 [GO] 2021―Aug―09 Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review Ekta Singh, Gurubasavaraja Swamy Purawarga Matada, Nahid Abbas, Prasad Sanjay Dhiwar, Abhishek Ghara, Arka Das
114 [GO] 2021―Jul―31 Recent updates on immunological, pharmacological, and alternative approaches to combat COVID-19 Ammara Saleem, Muhammad Furqan Akhtar, Muhammad Haris, Mohamed M. Abdel-Daim
115 [GO] 2021―Jul―19 COVID-19 vaccines and decreased transmission of SARS-CoV-2 A. Vitiello, F. Ferrara, V. Troiano, R. La Porta
116 [GO] 2021―Jul―09 SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism Ali Sepehrinezhad, Ali Gorji, Sajad Sahab Negah
117 [GO] 2021―Jul―05 Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly Adel A. Gomaa, Hamdy S. Mohamed, Rasha Bakheet Abd-ellatief, Mohamed A. Gomaa
118 [GO] 2021―Jun―29 Shedding light on vitamin D: the shared mechanistic and pathophysiological role between hypovitaminosis D and COVID-19 risk factors and complications Esraa Menshawey, Rahma Menshawey, Omnia Azmy Nabeh
119 [GO] 2021―Jun―10 Role of vitamins and minerals as immunity boosters in COVID-19 Puneet Kumar, Mandeep Kumar, Onkar Bedi, Manisha Gupta, Sachin Kumar, Gagandeep Jaiswal, et al. (+5)
120 [GO] 2021―May―03 Brief review of the mRNA vaccines COVID-19 Antonio Vitiello, Francesco Ferrara
121 [GO] 2021―Apr―21 The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis Chia Siang Kow, Syed Shahzad Hasan
122 [GO] 2021―Apr―06 Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection Menizibeya O. Welcome, Nikos E. Mastorakis
123 [GO] 2021―Mar―15 Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting Sreedhar Amere Subbarao
124 [GO] 2021―Feb―20 Correction to: COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties Muhammad Asif, Mohammad Saleem, Malik Saadullah, Hafiza Sidra Yaseen, Raghdaa Al Zarzour
125 [GO] 2020―Nov―16 COVID-19 and nutriceutical therapies, especially using zinc to supplement antimicrobials Desley Butters, Michael Whitehouse
126 [GO] 2020―Nov―07 The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients Apurva Hariharan, Abdul Rahman Hakeem, Subathra Radhakrishnan, Mettu Srinivas Reddy, Mohamed Rela
127 [GO] 2020―Sep―12 ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror Mina T. Kelleni
128 [GO] 2020―Aug―14 A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality Lucinda Smart, Neil Fawkes, Paul Goggin, Graham Pennick, K. D. Rainsford, Bruce Charlesworth, Neil Shah
129 [GO] 2020―Aug―14 COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties Muhammad Asif, Mohammad Saleem, Malik Saadullah, Hafiza Sidra Yaseen, Raghdaa Al Zarzour
130 [GO] 2020―Jul―07 A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms Kevin Roe
 [1] 

130 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.014 sec